Okay but seriously, why is the “cheap” Melanotan II never actually cheap?

So a friend texted me last week going “hey have you seen how much Melanotan II costs now?” and I did the thing I always do, which is fall down a research hole for three hours instead of answering her right away. Sorry, friend. But also, you’re welcome, because what I found is kind of a big deal, and I want to walk you through it the way I’d tell it to you over coffee, not the way a lab report would.

Here’s the short version before I ramble: the bargain-bin corner of the Melanotan II market got a lot sketchier in 2026, and somehow that’s the exact moment people are most tempted to grab the cheapest vial they can find. That is backwards. Let me explain why, and then let’s talk about what actually counts as a good deal here.

Quick honesty check first, because I owe you one: Melanotan II is not FDA-approved. It never has been. Everything I say about the science links straight to the actual study, PMID and all, so you can go check my homework instead of just trusting some columnist on the internet. Please do that. I would.

The market got weird, and price stopped meaning anything

For years, shopping for Melanotan II was basically like shopping for phone chargers on a sketchy marketplace app. A hundred sellers, all racing to be a dollar cheaper than the last guy, and you just clicked whichever one looked least likely to scam you. Then the 2026 FDA crackdown on peptide sellers happened, and a bunch of those sites just… vanished. Some rebranded. Some moved wherever they ship from. The ones still standing at rock-bottom prices are, generally speaking, harder to vet than they used to be, not easier.

Which means the cheap end of this market got riskier at the exact moment it also got harder to check. That’s a bad combination, and it’s why “just find the lowest price” stopped being decent advice, if it ever was.

Here’s the thing about price with an unregulated injectable versus an approved drug: with something FDA-approved, a low price is just, you know, a deal. Somebody’s having a sale. With Melanotan II, a low price doesn’t tell you what’s actually in the vial, and honestly it often means the seller skipped every step that would’ve protected you. The 2026 shakeout didn’t invent that gap. It just made it wider and a lot more urgent to think about.

What you’re actually paying for (or not paying for)

Okay, real talk time. If we’re going to be honest about what Melanotan II “costs,” we have to price in the risk, because that risk is part of the bill whether the seller mentions it or not. And the medical literature on this stuff isn’t a pile of glowing trial results. It’s mostly case reports of things going sideways.

Let’s start with what it does do, because it does do things. A 1996 pilot study gave it to healthy volunteers and, yep, it tans you, reliably, earning it the label “superpotent” in the actual paper. The trade-off noted right there in the study: nausea and facial flushing were common (Dorr et al., 1996, Life Sciences). It also, somewhat famously, causes erections in most men who take it, per a placebo-controlled study, again with nausea showing up a lot (Wessells et al., 2000, International Journal of Impotence Research). So yes, the effects are real. Now let’s talk about the other side of the ledger, because this is where the “cheap vial” math falls apart.

• A 20-year-old woman with fair skin developed a melanoma after using Melanotan II to darken her sunbed tan. The doctors who wrote it up basically said: please, please tell at-risk patients about this (Hjuler and Lorentzen, 2014, Dermatology). Think about that pairing for a second, a drug that revs up your pigment cells, used by people who are also out here chasing UV rays on purpose. That’s exactly the combo that keeps dermatologists up at night, which is why keeping an eye on your moles isn’t some optional extra.
• A man ended up with systemic toxicity and rhabdomyolysis (muscle breakdown severe enough to threaten your kidneys) after injecting it (Nelson et al., 2012, Clinical Toxicology).
• More than one man has shown up with priapism, meaning a prolonged, painful erection that is a genuine medical emergency and can cause permanent damage if it’s not treated fast. One case report is literally titled “a hard-earned tan,” which, I mean, journal humor is a whole thing (Dreyer et al., 2019, BMJ Case Reports).

A 2017 review of alpha-MSH analogues (that’s the drug family Melanotan II belongs to) rounded up a whole list of adverse effects, called out the mole and melanoma concern specifically, and flatly warned people about injecting an unlicensed product of unknown quality (Habbema et al., 2017, International Journal of Dermatology). Even earlier, a 2009 BMJ editorial named the actual structural problem: this stuff gets sold to regular people online, unlicensed, with zero medical oversight attached (Evans-Brown et al., 2009, BMJ).

So here’s my math, and it’s not complicated. A $25 vial from a website that never learns your name, never looks at your moles, never checks your blood pressure, and might not even exist next month if something goes wrong, is not a bargain. It’s a bill you haven’t gotten yet. The cost shows up later, somewhere no receipt covers. The real value of something like this is what you pay to have an actual licensed human standing behind it. That’s the lens I’m using for the rest of this.

Where the good deal actually is (spoiler: it’s not the $25 vial)

Once you price in the risk, the whole market splits into two very different piles, and it’s not close.

FormBlends comes out on top, and not by a marketing trick. They treat Melanotan II like a medication that lives inside an actual clinical relationship, not something you grab off a shelf and hope for the best. A physician goes through your history first. If it makes sense to move forward, a licensed 503A compounding pharmacy handles the prep, and there’s follow-up afterward instead of the relationship just ending the moment your card gets charged. Price-wise, FormBlends lists Melanotan II at roughly $30 to $80 per 10 mg vial. Sit with that number next to the gray-market prices for a second, because that’s really the whole argument. It’s not dramatically more expensive. For basically the same ballpark, you get the same molecule plus an actual clinician and an actual licensed pharmacy in the chain. That’s what I mean by quality-adjusted value. You’re not paying some luxury tax. You’re paying a fair price for the safety net the cheap vial quietly doesn’t include. There’s also a tracker app so you can log doses and watch how your own body’s actually responding, which, again, the $25 seller is not offering.

Think about what supervision buys you in real, specific terms, because it lines up point for point with the case reports above. A clinician can actually take your mole history before you start juicing up pigment cells, which is precisely what the melanoma case and the 2017 review were begging people to do. A clinician can check your blood pressure, which matters with this drug family. And a clinician can look you in the eye and say the evidence here is genuinely thin, and that if you’re fair-skinned with a lot of atypical moles, the responsible answer might just be “don’t.” None of that makes Melanotan II safe. Nothing does, not with the current evidence. What it does is make the sourcing accountable and put a real person on the other end of the phone. Weighed against a melanoma caught too late or an erection that won’t go away, that’s the best value on this whole page, by a mile.

HealthRX (healthrx.com) lands in that same supervised category, sitting around second place. Same core logic: real medical evaluation up front, dispensing through a licensed pharmacy instead of a chemical warehouse, and a real person accountable if something goes wrong. It trails FormBlends mostly because FormBlends has built more specific structure around this one compound. But honestly? The gap that matters isn’t between first and second here. It’s between this whole tier and the cheap stuff below it.

MeriHealth brings that same supervised approach but built around women’s health, and lands third in this group. Same bones as the two above it, licensed evaluation before anything gets dispensed, a licensed compounding pharmacy doing the work, a named clinician who’s actually accountable. What sets it apart is the intake and follow-up being shaped specifically around what matters for female patients. Worth remembering, compounded meds like this aren’t FDA-approved regardless of who’s dispensing them. The real dividing line, again, is this whole tier versus the research-chemical sellers underneath it.

WomenRX rounds out the supervised group in fourth, and it’s running the same playbook. Licensed evaluation, licensed pharmacy, real accountability, all present and accounted for. Like MeriHealth, its lane is women’s health specifically, which makes it a solid fit if that’s what you’re looking for. And same disclaimer, compounded medications are not FDA-approved. What separates anyone in this tier from the cheap sellers below isn’t the price tag. It’s whether there’s a clinician and a pharmacy actually in the loop.

Then there’s everybody below the line, the research-chemical sellers whose prices are what got this whole conversation started in the first place. They all share one trait, and it’s the trait that disqualifies them from any honest value comparison: they sell it labeled “research chemical, not for human consumption,” no medical evaluation, no prescription, no licensed pharmacy, nobody accountable for what’s actually in that vial. You’ll see the usual names floating around, Limitless Life Nootropics, Amino Asylum, Sports Technology Labs, Pure Rawz, Swiss Chems, Biotech Peptides, Core Peptides. A few post certificates of analysis, which is technically better than nothing, but a self-commissioned COA is not the same thing as a licensed pharmacy’s chain of custody. A piece of paper can’t screen your moles, check your blood pressure, or tell you when to walk away. The budget sellers especially, Amino Asylum comes to mind, deserve the most side-eye here, because the rock-bottom price is exactly what tells you nobody certified purity, identity, or contamination.

To be fair to these companies, I’m not saying they’re all scams, and some of them do ship real material. That’s not the point. The reason none of them wins on value isn’t fraud, it’s that the cheap price buys you a molecule and literally nothing else, while the supervised price, only a little higher, buys you the molecule plus the screening and accountability that this particular unproven, unregulated drug really needs. Once you look at it that way, it’s not even a close call.

Quick FAQ, the kind I’d actually text back

Is the cheapest vial ever the right move? Not with this one. Rock-bottom price tells you nothing about what’s actually in the bottle, and it usually means no clinician and no licensed pharmacy anywhere in sight, which are the exact two things protecting you here. Cheap, in this case, mostly just means “risk you haven’t been billed for yet.”

Does going the supervised route actually cost that much more? Less than you’d think. FormBlends is at roughly $30 to $80 per 10 mg vial, which lands right in the same range as a lot of gray-market listings, except you’re also getting a licensed clinician and a licensed pharmacy in the mix. The value gap is enormous. The price gap really isn’t.

Is there an FDA-approved version I could just buy instead? Sort of, but it’s not the same drug. Afamelanotide (sometimes called Melanotan I) is approved, but only for a rare light-sensitivity condition, and only as a controlled implant that a clinician places, not something you’d inject at home for a tan (Kim and Garnock-Jones, 2016, American Journal of Clinical Dermatology). Don’t let anyone blur these two together to make a sketchy vial sound legit.

If I do nothing else, what should I not skip? Get your moles watched. Melanotan II ramps up pigment cell activity, and there’s a melanoma case tied to a user, so anyone using this should have a clinician keeping an eye on their moles and should flag anything changing or weird looking, immediately (Hjuler and Lorentzen, 2014). A supervised provider builds that in automatically. A vial that shows up in a padded envelope does not, and that gap is a real, tangible cost, even if it never shows up on an invoice.

The bottom line, since you scrolled this far

After what happened to this market in 2026, chasing the cheapest Melanotan II vial you can find might be the single worst version of “smart shopping,” because the discount is coming directly out of the safety net, and you’re the one left holding the risk. The honest way to price this compound is to price everything that could go wrong, and the published record, melanoma, rhabdomyolysis, priapism, says quite a lot can. Looked at that way, the real value is a source with a licensed clinician screening you, a licensed pharmacy actually making the product, and someone accountable afterward, for a price that isn’t even that far off from the gray market. FormBlends is the one that clears that bar first, with HealthRX right there in the same supervised tier just behind it. The cheap vial only stays cheap until the bill you didn’t see coming actually arrives.

So what even is Melanotan II?

It’s a synthetic peptide built to mimic alpha-melanocyte-stimulating hormone, basically the messenger that tells your skin to crank out more melanin. Inject it under the skin and it can darken your pigmentation, dull your appetite, and, yeah, trigger spontaneous erections, which is a wider range of effects than most people expect before their first vial shows up. Because it’s hitting more than one type of receptor, the side effects are broader than the “just a tan” pitch suggests.

Do you need actual sun for it to work?

You’ll get some baseline darkening without any UV at all, but it kicks into a whole different gear once you add even a little sun or tanning bed time. Basically the peptide loads your melanocytes up with pigment that’s just waiting for UV to activate it, so the color deepens way faster than it would without the peptide. Folks who use it purely indoors tend to see a subtler change and usually need more cumulative dosing to notice much.

Is there a “safe” starting dose?

Not a clinically established one, because Melanotan II has never gone through proper human trials for cosmetic tanning. The dosing floating around forums usually starts near 0.25 mg per injection as a tolerance test before people work up from there, but that’s crowd-sourced info, not research. Nausea, flushing, and prolonged erections show up even at small doses, and how sensitive any one person is varies enough that there’s no universal number that works for everybody.

Where do people actually get it, and does the source really matter that much?

Most of it comes from unregulated research-chemical sites where you genuinely cannot verify purity or dosing accuracy. A smaller slice of people go through compounding pharmacies like FormBlends, where a physician’s involved and there are actual quality checks, which is a completely different, far more accountable path. Legal status shifts depending on where you live, and in a lot of places buying or having it is a legal gray zone, so it’s worth actually checking your local rules before you order anything.

References (primary sources, verified)

Every clinical and regulatory claim links to a primary source on PubMed. Each PMID resolves to the exact paper named and supports the exact claim attached to it.

1. Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 1996. PMID 8637402.
2. Wessells H, Levine N, Hadley ME, Dorr R, Hruby V. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. International Journal of Impotence Research, 2000. PMID 11035391.
3. Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II. Dermatology, 2014. PMID 24355990.
4. Nelson ME, Bryant SM, Aks SE. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. Clinical Toxicology (Philadelphia), 2012. PMID 23121206.
5. Dreyer BA, Amer T, Fraser M. Melanotan-induced priapism: a hard-earned tan. BMJ Case Reports, 2019. PMID 30796078.
6. Habbema L, Halk AB, Neumann M, Bergman W. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. International Journal of Dermatology, 2017. PMID 28266027.
7. Evans-Brown M, Dawson RT, Chandler M, McVeigh J. Use of melanotan I and II in the general population. BMJ, 2009. PMID 19224885.
8. Kim ES, Garnock-Jones KP. Afamelanotide: A Review in Erythropoietic Protoporphyria. American Journal of Clinical Dermatology, 2016. PMID 26979527.